125 related articles for article (PubMed ID: 7145769)
1. The pathologic features and behavior of endometrial carcinoma associated with exogenous estrogen administration.
Robboy SJ; Miller AW; Kurman RJ
Pathol Res Pract; 1982 Aug; 174(3):237-56. PubMed ID: 7145769
[No Abstract] [Full Text] [Related]
2. Comparison of estrogen-induced hyperplasia to endometrial carcinoma.
Bhagavan BS; Parmley TH; Rosenshein NB; Jefferys JL; Grisso JA; Stolley PD
Obstet Gynecol; 1984 Jul; 64(1):12-5. PubMed ID: 6738936
[TBL] [Abstract][Full Text] [Related]
3. Endometrial carcinoma: histopathology, survival, and exogenous estrogens.
Smith DC; Prentice RL; Bauermeister DE
Gynecol Obstet Invest; 1981; 12(4):169-79. PubMed ID: 7250780
[TBL] [Abstract][Full Text] [Related]
4. Malignant and pseudomalignant hyperplasia adenomatosa of the endometrium in postmenopausal women treated with oestrogen.
Ostergaard E
Acta Obstet Gynecol Scand Suppl; 1974; 29():97-102. PubMed ID: 4526169
[No Abstract] [Full Text] [Related]
5. Oestrogens and endometrial hyperplasia.
Thom MH; Studd JW
Br J Hosp Med; 1980 May; 23(5):506, 508-9, 511-3. PubMed ID: 6992895
[TBL] [Abstract][Full Text] [Related]
6. Changing trends and prognostic features in endometrial cancer associated with exogenous estrogen therapy.
Robboy SJ; Bradley R
Obstet Gynecol; 1979 Sep; 54(3):269-77. PubMed ID: 471366
[TBL] [Abstract][Full Text] [Related]
7. Endometrial cancer and estrogen use. Report of a large case-control study.
Antunes CM; Strolley PD; Rosenshein NB; Davies JL; Tonascia JA; Brown C; Burnett L; Rutledge A; Pokempner M; Garcia R
N Engl J Med; 1979 Jan; 300(1):9-13. PubMed ID: 213722
[TBL] [Abstract][Full Text] [Related]
8. Sex steroids and cancer.
Gambrell RD
Obstet Gynecol Clin North Am; 1987 Mar; 14(1):191-206. PubMed ID: 3306519
[TBL] [Abstract][Full Text] [Related]
9. Exogenous estrogens and endometrial carcinoma.
Reeves KO; Kaufman RH
J Reprod Med; 1977 Jun; 18(6):297-300. PubMed ID: 881682
[No Abstract] [Full Text] [Related]
10. The estrogen--cancer controversy.
Greenblatt RB; Stoddard LD
J Am Geriatr Soc; 1978 Jan; 26(1):1-8. PubMed ID: 618948
[TBL] [Abstract][Full Text] [Related]
11. Effect of progesterone on cell division in chemically induced endometrial hyperplasia and adenocarcinoma in mice.
Kimura J
Cancer Res; 1978 Jan; 38(1):78-82. PubMed ID: 618585
[No Abstract] [Full Text] [Related]
12. Severe atypical endometrial changes and sequential contraceptive use.
Kaufman RH; Reeves KO; Dougherty CM
JAMA; 1976 Aug; 236(8):923-6. PubMed ID: 988889
[TBL] [Abstract][Full Text] [Related]
13. Association of exogenous estrogen and endometrial carcinoma.
Smith DC; Prentice R; Thompson DJ; Herrmann WL
N Engl J Med; 1975 Dec; 293(23):1164-7. PubMed ID: 1186789
[TBL] [Abstract][Full Text] [Related]
14. [Pathology of endometrial hyperplasia and endometrial carcinoma (author's transl)].
Namiki T
Rinsho Byori; 1979 Nov; 27(11):1020-5. PubMed ID: 544832
[No Abstract] [Full Text] [Related]
15. New aspects of endometrial carcinoma.
Silverberg SG
Clin Obstet Gynaecol; 1984 Apr; 11(1):189-208. PubMed ID: 6370532
[TBL] [Abstract][Full Text] [Related]
16. ARS Presidential Address: Estrogen therapy: a causal role in endometrial cancer?
Rutledge FN
AJR Am J Roentgenol; 1976 Dec; 127(6):897-9. PubMed ID: 998825
[TBL] [Abstract][Full Text] [Related]
17. [Endometrial adenocarcinoma in women younger than 40 years].
Bachmann FF
Zentralbl Gynakol; 1973 Dec; 95(49):1729-42. PubMed ID: 4779192
[No Abstract] [Full Text] [Related]
18. Endometrial carcinoma and its precursors.
Dallenbach-Hellweg G
Patol Pol; 1985; 36(1):23-31. PubMed ID: 4047742
[No Abstract] [Full Text] [Related]
19. Hyperplasia and carcinoma of the endometrium.
Silverberg SG
Semin Diagn Pathol; 1988 May; 5(2):135-53. PubMed ID: 3041508
[TBL] [Abstract][Full Text] [Related]
20. Review of epidemiologic studies of endometrial cancer and exogenous estrogen.
Cramer DW; Knapp RC
Obstet Gynecol; 1979 Oct; 54(4):521-6. PubMed ID: 492641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
